Affiliation:
1. Department of Pathology and Laboratory Medicine, Emory University School of Medicine, Atlanta, Georgia, USA
Abstract
ABSTRACT
The mandated testing of blood components for infectious diseases, to prevent transfusion-transmitted infections (TTIs), began in the 1950s. Since then, changes in predonation questionnaires and advances in testing techniques have afforded more sensitive and specific tests for pathogens, in addition to allowing earlier detection. Given that these approaches have very low but detectable failure rates, the recent development and implementation of proactive pathogen reduction approaches is the new forefront of TTI prevention strategies. With globalization and the ability of pathogens to evolve rapidly, continuous redefining of testing standards and laboratory techniques is paramount for maintaining a safe blood supply.
Publisher
American Society for Microbiology
Reference48 articles.
1. Code of Federal Regulations. 2017. Title 21 (Food and Drugs). Parts 610 (General biological products standards) and 630 (Requirements for blood and blood components intended for transfusion or for further manufacturing use). U.S. Government Printing Office, Washington, DC. https://www.ecfr.gov/cgi-bin/text-idx?SID=c5d21c85fde27aa575d5a50814d915e6&mc=true&tpl=/ecfrbrowse/Title21/21cfrv7_02.tpl#0.
2. Posttransfusion Hepatitis After Open-Heart Operations
3. Posttransfusion Hepatitis After Exclusion of Commercial and Hepatitis-B Antigen-Positive Donors
4. Antibody to Hepatitis B Core Antigen as a Paradoxical Marker for Non-A, Non-B Hepatitis Agents in Donated Blood
5. Donor Transaminase and Recipient Hepatitis
Cited by
41 articles.
订阅此论文施引文献
订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献